Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Production of Pharmaceuticals01:30

Production of Pharmaceuticals

90
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
90
Bioreactor Controls-III01:22

Bioreactor Controls-III

67
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

17
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
17
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

2.0K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
2.0K
Bioreactor Controls-I01:28

Bioreactor Controls-I

92
Maintaining optimal conditions within fermenters is essential for maximizing microbial productivity and ensuring process efficiency. This lesson focuses on key parameters—temperature, foam, pH, carbon dioxide, oxygen, and pressure—and their precise measurement and control strategies in fermentation systems.Temperature ControlTemperature regulation is critical due to the exothermic nature of many fermentation processes. In small laboratory fermenters, temperature is commonly...
92

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is There an Association Between Industry Payments and the Reported Results after Nerve Repair Using Conduits or Grafts? A Systematic Review.

Plastic and reconstructive surgery·2025
Same author

Pathways to Leadership in Plastic Surgery: A Cross-sectional Study.

Plastic and reconstructive surgery. Global open·2025
Same author

Crush nerve injury model in the rat sciatic nerve: A comprehensive review and validation of various methods.

Journal of neuroscience methods·2025
Same author

Synthetic conduits efficacy in neural repair: a comparative study of dip-coated polycaprolactone and electrospun polycaprolactone/polyurethane conduits.

Journal of neural engineering·2024
Same author

Evaluation of Dexamethasone-Eluting Cell-Seeded Constructs in a Preclinical Canine Model of Cartilage Repair.

Tissue engineering. Part A·2024
Same author

The Future of Microsurgery: Vascularized Composite Allotransplantation and Engineering Vascularized Tissue.

Journal of hand and microsurgery·2024

Related Experiment Video

Updated: Apr 25, 2026

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
09:35

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

10.4K

Bioreactors addressing diabetes mellitus.

Danielle M Minteer1, Jorg C Gerlach2, Kacey G Marra3

  • 1Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA.

Journal of Diabetes Science and Technology
|August 28, 2014
PubMed
Summary

Bioreactor technology, novel in biomedical engineering, is revolutionizing cell culture for diabetes therapies. This review explores bioreactor history and emerging technologies for treating diabetes mellitus.

Keywords:
bioreactorcell culturediabetes mellitusdiabetes treatments

More Related Videos

Nutrient Regulation by Continuous Feeding for Large-scale Expansion of Mammalian Cells in Spheroids
11:01

Nutrient Regulation by Continuous Feeding for Large-scale Expansion of Mammalian Cells in Spheroids

Published on: September 25, 2016

7.0K
An In Ovo Model for Testing Insulin-mimetic Compounds
06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

11.5K

Related Experiment Videos

Last Updated: Apr 25, 2026

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
09:35

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

10.4K
Nutrient Regulation by Continuous Feeding for Large-scale Expansion of Mammalian Cells in Spheroids
11:01

Nutrient Regulation by Continuous Feeding for Large-scale Expansion of Mammalian Cells in Spheroids

Published on: September 25, 2016

7.0K
An In Ovo Model for Testing Insulin-mimetic Compounds
06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

11.5K

Area of Science:

  • Biomedical Engineering
  • Biochemical Engineering
  • Tissue Engineering

Background:

  • Bioreactors are established in biochemical engineering but novel in biomedical and tissue engineering.
  • Bioreactor technology has been rapidly adopted as a cell culture model.
  • Tissue engineers utilize bioreactors for culturing diverse cell types and therapies.

Purpose of the Study:

  • To review the history of bioreactors.
  • To highlight emerging bioreactor technologies.
  • To focus on applications in diabetes mellitus (types 1 and 2) cell culture and therapies.

Main Methods:

  • Literature review of bioreactor development.
  • Analysis of bioreactor applications in cell culture.
  • Focus on diabetes-related research and therapeutic strategies.

Main Results:

  • Bioreactors offer advanced culture models for various cell types.
  • Specific bioreactor designs are being adapted for diabetes therapies.
  • The field shows rapid development and increasing clinical relevance.

Conclusions:

  • Bioreactor technology is a significant advancement for biomedical and tissue engineering.
  • Emerging bioreactor applications show promise for diabetes mellitus treatment.
  • Continued innovation in bioreactors is crucial for future cell-based therapies.